...pharmaceutical subsidiary,
Clover Therapeutics. The new unit will aim to develop drugs that treat chronic
conditions common in seniors, beginning with macular degeneration and other eye
diseases. Clover Health currently has 40,411 members in seven states, all
enrolled in MA plans.
No comments:
Post a Comment